diarrhea retatrutide Subcutaneous Fat Loss Results: What Clinical Trials Reveal About Effectiveness and Safety does retatrutide cause diarrhea Retatrutide

(2025) 17:e94926

The FDA prescribing information for semaglutide and tirzepatide lists fatigue as an adverse reaction occurring in clinical studies, with incidence rates typically ranging from 5-11% depending on the specific product and dosage

These can be signs of an infection or a total blockage, which require urgent care

As recommended above, its best to take your dose of oral GLP-1 on an empty stomach for the best absorption

If your provider determines these are necessary for your specific health plan, they may qualify as eligible expenses

These providers make clinical decisions based on the health information patients provide